Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs FuturHealth

AgelessRx
Graded #24

Higher grade

vs+18.700000000000003
FuturHealth
Graded #215

Lower grade

The verdict

AgelessRx takes it — 84.3/100 to 65.6/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the lowest compounded-semaglutide pricing, with some brand-name access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgelessRx +30
90
60
Dose & formulationFuturHealth +1
80
81
Clinical oversightAgelessRx +16
83
67
Labs & monitoringAgelessRx +21
82
61
FulfillmentAgelessRx +22
84
62
Contract termsAgelessRx +30
85
55
AgelessRx · left barFuturHealth · right bar

The numbers

MetricAgelessRxFuturHealth
WeighScore84.3/10065.6/100
GradeBC
Scorecard rank#24#215
Semaglutide$139/mo$199/mo (compounded)
TirzepatideNot disclosedNot disclosed
CoverageNot disclosedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
AgelessRx

Graded #24 · B

Strengths

  • Low-end semaglutide pricing
  • Some brand-name access
  • Established brand

Where it loses points

  • Tirzepatide pricing not disclosed
  • States not disclosed
FuturHealth

Graded #215 · C

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard